Evaluation of Endothelial Dysfunction During Aortic Valvular Replacement by Bioprosthesis With and Without Extracorporeal Circulation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

51 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-05

Study Completion Date

2019-01-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients with aortic stenosis present many risk factors for endothelial dysfunction (arterial hypertension, arteriosclerosis, dyslipidemia, chronic renal insufficiency, etc.). It is likely that a significant number of patients suffer from pre-existing endothelial dysfunction that can be evaluated by a molecular approach.

To date, the replacement of the aortic valve can be performed by surgery with extracorporeal circulation (CEC) or percutaneous (Transcatheter Aortic Valve ImplantationTAVI) without CEC.

Two recent studies have demonstrated a sustained improvement in endothelial function with TAVI. On the contrary, studies have demonstrated that post-operative complications (coagulopathy, capillary leak syndrome, acute vasoplastic disorder and acute renal failure) after surgery with extracorporeal circulation (CEC) could be the result of the interaction between pre-existing endothelial dysfunction And the "operative" aggression associated with the CEC.

Thus, patients with preexisting involvement of endothelial function would develop vascular dysfunction after valvular replacement due to "endothelial activation" related to CEC. This phenomenon would not exist in TAVI, and would explain the absence of so-called vascular dysfunction complications (Systemic inflammatory response syndrome, vasoplastic syndrome, disseminated intravascular coagulation).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment of TRanscathetEr and Surgical Aortic BiOprosthetic Valve Thrombosis and Its TrEatment With Anticoagulation

NCT02318342

Prosthetic Valve Thrombosis

RECRUITING NA

Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients

NCT02701283

Aortic Valve Stenosis

ACTIVE_NOT_RECRUITING NA

Retrospective Observational Study of Patients With a Sutureless Aortic Valve Implanted in the Cardiovascular and Thoracic Surgery Department of Dijon CHU

NCT03259945

Patients With a Sutureless Aortic Valve

COMPLETED

Geriatric Evaluation to Predict Mortality and Functional Recovery After Trans Aortic Valve Implantation

NCT02424370

Symptomatic Aortic Stenosis

COMPLETED

Long-term Prognosis and Valve Durability of TAVR

NCT06379386

Aortic Valve Stenosis and Insufficiency

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Endothelial Dysfunction Aortic Valve Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Surgery with CEC

Study of endothelial function biological markers

Intervention Type OTHER

Study of endothelial function biological markers

Without CEC

Study of endothelial function biological markers

Intervention Type OTHER

Study of endothelial function biological markers

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Study of endothelial function biological markers

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient ≥ 18 years.
* Patient operated on aortic valvular replacement by bioprosthesis in surgery + CEC or TAVI
* Signed consent.
* Affiliation to Social Security

Exclusion Criteria

* Any other cardiac surgery
* Mechanical aortic valve replacement
* Permanent Ac / Fa.
* Pregnant woman.
* Curative anticoagulation (AVK, NANCO, heparin).
* Patient under tutelage or curatelle.
* Refusal of the patient.
* Participation in another study.
* Preoperative sepsis
* Minor or adult, under guardianship or curatorship

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No